bionity.com News
After years of debate, progress is being made in the development of new plant varieties. With its approval, the European Parliament is paving the way for New Genomic Technologies (NGT) in plant breeding. This will allow plants, for example, to be better adapted to climate change. The German Industry...
Bavaria’s biotechnology sector continues its growth trajectory. Despite a challenging global market environment, the number of companies in Bavaria’s biopharma sector increased to 548 (+1,5%) in 2025. At the same time, 26 new start-ups were founded (+62,5%) while funding and financing reached a new ...
For more than a hundred years, chemists have been building complex molecules step by step – bond by bond, atom by atom. But what if, instead of painstakingly reassembling molecules, they could be directly "rewritten"? This is exactly what a research team led by organic chemist Nuno Maulide from the ...
Consider what we ask of a clinical trial. We gather people who differ in nearly every way that matters, we give them the same drug at the same dose, and then we average the result and call the average truth. Most of the time the trick holds. Sometimes it lies. A new study published in Genomic Psychi...
Our food and our bodies are full of tiny protein fragments called peptides. These small chains of amino acids act as biological messengers, influencing processes ranging from sensory perception to physiological functions. Recent advances in omics technologies have provided unprecedented insights int...
A new study finds that adults who simply breathe in secondhand cigarette smoke have about 1.5 times more of the toxin cadmium in their blood than people in smoke-free environments. "We knew that cigarette smoke exposes people to cadmium, but until now, we didn't know about the association with secon...
Monash University researchers have found in laboratory experiments that a drug which delivers copper to the brain significantly reduces toxic Alzheimer's proteins and improves long-term spatial memory. The study, published today in the journal ACS Chemical Neuroscience, shows the compound Cu(ATSM) r...
Variants in the DHDDS gene cause a severe neurodegenerative condition, characterised by tremors, seizures, coordination and learning difficulties, usually manifesting in early childhood. This Parkinson's-like condition is extremely rare, and until recently, parents were told that there was nothing t...
Researchers from ETH Zurich have developed a molecular switch that is controlled by light. It wakes lung cancer cells up from a protective dormant state so that they are more accessible for treatment. Tumour cells can lapse into a sleep-like state and thereby evade the destructive effect of cancer d...
VEGA Grieshaber KG, a measurement technology manufacturer based in Schiltach, is continuing to expand its international presence. At the end of May, the company officially launched and celebrated the grand opening of a new facility in Jiaxing, China. Following the expansion of its electronics manufa...
CollimateHealth GmbH, a pioneering life sciences start-up for next-generation radiation therapy, announced the close of its €6 million seed financing round. The round was significantly oversubscribed and supported by renowned life sciences investors including VP Venture Partners, Positron, XISTA Sci...
Probiotics can help reduce the use of antibiotics in livestock farming in order to counteract the development of antibiotic resistance. Evonik’s probiotic Ecobiol PRO germinates particularly quickly in the chicken intestine, thereby improving animal survival. This is enabled by a specific manufactur...
A new study shows that deep learning can predict how fast biochar materials break down antibiotic contaminants, offering a faster path toward cleaner water and smarter environmental remediation. Antibiotic pollution is an increasing environmental and public health concern. These compounds can enter ...
Ona Therapeutics, a global biopharmaceutical company pioneering first-in-class antibody-drug conjugates (ADCs) to address treatment-resistant cancers, announced the closing of an oversubscribed $86.6 million Series B financing. The round was co-led by new investors Columbus Venture Partners and Méri...
An estimated five to eight percent of people in Germany suffer from an autoimmune disease such as asthma, rheumatoid arthritis, or inflammatory bowel disease. Developing new drugs to treat these conditions is a lengthy and complex process. To significantly accelerate research, Markus Rehberg works a...
Researchers at the Monell Chemical Senses Center found that common dietary sugars fructose and glucose, despite having the same amount of calories, communicate with the brain through different gut-brain pathways, a difference that may help shape our food and beverage preferences. In mice, the team i...

Nuvisan announced it has received a US$25 million grant from the Gates Foundation to advance a portfolio of novel non-hormonal contraceptive drug discovery projects. The new three-year grant builds on a successful program, delivered over the past three years. It is intended to further expand the ...
Many of the deadliest forms of cancer are caused by a pathological mutation in the RAS protein. Yet, to date, no effective treatment for this cancer protein has been found. A new research approach aims to prevent the protein from forming in the first place by destroying its blueprint – the mRNA. Bas...
A new AI model has become so good at predicting how molecules evolve over time that, in the future, it could speed up the costly and time-consuming process of testing new drugs. In the long term, this technology could facilitate the development of medicines and new treatments, as promising drug cand...
research.ioSign up to keep scrolling
Create your feed subscriptions, save articles, keep scrolling.







